Evivo Probiotic Drops Earn Mom's Choice Award, Joining Brand's Powder

The dual recognition matters for shelf positioning. Infant probiotics are a crowded category, with brands like Culturelle, Gerber, and Garden of Life all marketing drops and powders to new parents. A Mom's Choice seal occupies real estate on product packaging and search results. For a brand like Evivo, which competes on a proprietary strain rather than price or distribution breadth, the endorsement carries weight with the target buyer: parents who research before purchase.

Evivo's proprietary strain is Bifidobacterium longum subsp. infantis EVC001. It feeds on human milk oligosaccharides, complex nutrients naturally found in breast milk and now added to select infant formulas. The brand says EVC001 is among the most extensively researched B. infantis strains in the world. The strain is exclusive to Evivo products, meaning no competitor can claim the same clinical data.

The clinical research backing EVC001 includes studies on gut microbiome composition, reduced inflammation markers, and lower levels of potentially pathogenic bacteria in full-term infants. Infinant Health publishes a bibliography on its website under "EVC001 Research" for healthcare professionals and parents who want to verify the claims.

Infinant Health is based in Sacramento, California. The company was founded by a group of microbiome researchers who spun out of the University of California. It has raised venture funding from investors including the Bill & Melinda Gates Foundation, though it has not disclosed recent valuation figures.